Literature DB >> 19503108

Successful hematopoietic stem-cell transplantation in a patient with chronic granulomatous disease and McLeod phenotype sensitized to Kx and K antigens.

M Hönig, W A Flegel, K Schwarz, J F Freihorst, U Baumann, A Seltsam, K-M Debatin, A S Schulz, W Friedrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19503108      PMCID： PMC5662187          DOI： 10.1038/bmt.2009.115

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

Review 1.  The Kell blood group system: Kell and XK membrane proteins.

Authors:  S Lee; D Russo; C M Redman
Journal:  Semin Hematol       Date:  2000-04       Impact factor: 3.851

2.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

3.  Kell is not restricted to the erythropoietic lineage but is also expressed on myeloid progenitor cells.

Authors:  T Wagner; A Berer; G Lanzer; K Geissler
Journal:  Br J Haematol       Date:  2000-08       Impact factor: 6.998

4.  A "new" antibody associated with the Kell blood group system.

Authors:  M van der Hart; A Szaloky; J J van Loghem
Journal:  Vox Sang       Date:  1968-12       Impact factor: 2.144

5.  Onset of expression of the components of the Kell blood group complex.

Authors:  Jeffrey J Pu; Colvin M Redman; Jan W M Visser; Soohee Lee
Journal:  Transfusion       Date:  2005-06       Impact factor: 3.157

6.  Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation.

Authors:  Nobuhiro Suzuki; Naoki Hatakeyama; Masaki Yamamoto; Nobuo Mizue; Yuki Kuroiwa; Minami Yoda; Junko Takahashi; Yoshihiko Tani; Hiroyuki Tsutsumi
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

7.  Successful donor-lymphocyte infusion for extreme immune-hemolysis following unrelated BMT in a patient with X-linked chronic granulomatous disease and McLeod phenotype.

Authors:  U Kordes; T M C Binder; T H Eiermann; B Hassenpflug-Diedrich; M A Hassan; K Beutel; M Nagy; H Kabisch; R Schneppenheim
Journal:  Bone Marrow Transplant       Date:  2008-06-16       Impact factor: 5.483

8.  Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km.

Authors:  I Bansal; H-R Jeon; S R Hui; B W Calhoun; D W Manning; T J Kelly; S Lee; B W Baron
Journal:  Vox Sang       Date:  2007-12-18       Impact factor: 2.144

9.  Chronic granulomatous disease and the Mcleod phenotype. Successful treatment of infection with granulocyte transfusions resulting in subsequent hemolytic transfusion reaction.

Authors:  S M Brzica; A A Pineda; H F Taswell; K H Rhodes
Journal:  Mayo Clin Proc       Date:  1977-03       Impact factor: 7.616

Review 10.  Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.

Authors:  M Franchini; G Gandini; G Aprili
Journal:  Bone Marrow Transplant       Date:  2004-06       Impact factor: 5.483
  10 in total
  5 in total

1.  RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.

Authors:  Ross M Fasano; Alessandro Monaco; Emily Riehm Meier; Philippe Pary; A Hallie Lee-Stroka; John Otridge; Harvey G Klein; Francesco M Marincola; Naynesh R Kamani; Naomi L C Luban; David Stroncek; Willy A Flegel
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

Review 2.  Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.

Authors:  Elizabeth M Kang; Betty E Marciano; SukSee DeRavin; Kol A Zarember; Steven M Holland; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

Review 3.  Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics.

Authors:  Yazan Migdady; Yifan Pang; Shelley S Kalsi; Richard Childs; Sally Arai
Journal:  Blood Adv       Date:  2022-04-26

4.  Chronic granulomatous disease and McLeod syndrome: Stem cell transplant and transfusion support in a 2-year-old patient-a case report.

Authors:  Louise Helander; Chris McKinney; Kathleen Kelly; Samantha Mack; Mary Sanders; Janice Gurley; Larry J Dumont; Kyle Annen
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

Review 5.  Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.

Authors:  James A Connelly; Rebecca Marsh; Suhag Parikh; Julie-An Talano
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.